department
of anatomy
roose
lab

welcome

The Roose lab focuses on understanding cell fate decisions driven by cell-cell interactions and signaling pathways, in the context of cancer, autoimmune diseases, and COVID-19. Our collaborative research programs benefit from many technology platforms, such as organoids, CyTOF, single cell RNAseq, spectral flow, mouse models, and patient samples.

Dr. Roose is a co-founder of the Bakar ImmunoX initiative at UCSF and a co-lead investigator on the UCSF Endeavor Program that focuses on cancer metastasis, funded through the Mark Foundation for Cancer Research.
latest news
2021
DEC
  • Hugo’s paper in Cell
2021
OCT
  • Morgan joins the lab
2021
AUG
  • Collaboration with Senti Bio started
2021
JULY
  • COVID-19 patent filed
2021
JUNE
  • Leukemia R01 renewed
2021
JUNE
  • Milana, Kayla, Eric, Alan: off to amazing PhD/MD programs
2021
MAY
  • Provision COVID-19 patent filed
2020
DEC
  • Large collaborative program on metastatic cancer
2020
NOV
  • Laila’s paper in Oncogene
We are grateful for the financial support from the following agencies:
  • NIH/NIAID
  • NIH/NCI
  • Mark Foundation for Cancer Research
  • Bakar ImmunoX CoProject
  • Shorenstein Pancreatic Cancer Fund
  • AutoImmuno Profiler Program with Eli Lilly
  • SRA with 3T Biosciences
  • SRA with Senti Biosciences